Myocet
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Although doxorubicin (DXR) has been on the market for many years as an anti-cancer drug, a number of serious dose-limiting…
Despite the success in treating the majority of children with newly diagnosed acute leukemia, children with relapsed or…
Background: Advanced or recurrent endometrial cancer is associated with a poor prognosis, and results obtained with systemic…
Conventional chemotherapy regimens for the treatment of advanced Kaposi's sarcoma (KS) show limited efficacy and considerable…
OBJECTIVE
To ascertain the efficacy and tolerability of non-pegylated liposomal doxorubicin (Myocet) and epirubicin combined with…
Preclinical studies have established the pharmacologic advantages of liposomal anthracyclines, including pharmacokinetic profiles…
Conventional anthracyclines are active against many tumor types, but cardiotoxicity related to the cumulative dose may limit…
PURPOSE
To evaluate the safety and efficacy of liposomal doxorubicin (Myocet; Medeus Pharma Ltd, Herts,UK) when substituted for…